The Global Social Network
Punjab on Thursday has reported 216 additional coronavirus cases bringing the provincial tally to 3,232.
According to Punjab's Primary and Secondary Healthcare Department, 216 new cases surfaced in Punjab after which the number of provincial infections rose to 3,232.
Confirmed cases of COVID-19 has mounted to 6,521 with 124 fatalities in the country so far while the death toll in Punjab has rose to 34.
A day earlier, Punjab government had extended lockdown in the province till 25th of April while deciding to immediately re-open the low-risk sectors by ensuring implementation of SOPs to prevent the spread of COVID-19.
Punjab Chief Minister Usman Buzdar on Wednesday had announced to raise the testing capacity of COVID-19 in the province by 10,000.
In a statement, the CM Buzdar informed that soon Punjab will be able to conduct 10,000 coronavirus tests on daily basis.
More than 43,000 tests have so far been conducted in the province, he added.
CM also said that "the measures taken by the government to control deadly virus are giving fruitful outcomes."
Sardar Usman Buzdar further told that strategy is being formulated to provide relief to the general masses in Ramazan.
South Asia Investor Review
Investor Information Blog
Haq's Musings
Riaz Haq's Current Affairs Blog
After decades of failed attempts, the Government of Pakistan has finally privatized the Pakistan International Airline (PIA) under intense pressure from the International Monetary Fund (IMF). Nonetheless, it is a deal that will give the national airline not only a chance to survive but to thrive in the long run. As part of structuring the sale for Rs. 135 billion, the government has assumed Rs. 654…
ContinuePosted by Riaz Haq on December 25, 2025 at 10:30am
Several Pakistani pharmaceutical companies have started domestic production of generic versions of GLP-1 (Glucagon-Like Peptide-1) drugs Ozempic/Wegovy (Semaglutide) and Mounjaro/Zeptide (Tirzepatide). Priced significantly lower than the branded imports, these domestically manufactured generic drugs will increase Pakistanis' access and affordability to address the obesity crisis in the country, resulting in lower disease burdens and improved life quality and longer life expectancy. Obesity…
ContinuePosted by Riaz Haq on December 19, 2025 at 10:00am — 1 Comment
© 2025 Created by Riaz Haq.
Powered by
You need to be a member of PakAlumni Worldwide: The Global Social Network to add comments!
Join PakAlumni Worldwide: The Global Social Network